Find Therapeutics, a biopharmaceutical company in the clinical stage, has started administering doses of FTX-101 in its phase 1 clinical trial involving healthy participants. FTX-101 is a novel therapeutic peptide that controls the Plexin...
Zydus Lifesciences announced that their typhoid vaccine ZyVac TCV has been granted preliminary acceptance by the World Health Organisation (WHO). The WHO's pre-qualification will allow United Nations (UN) agencies to buy ZyVac TCV. ZyVac TCV is...
Angelini Pharma, a division of Angelini Industries, and Cureverse Inc., a startup company, revealed they have signed a unique worldwide option contract to develop and market Cureverse's groundbreaking brain health asset CV-01. According to the...
Thermo Fisher Scientific, the global leader in scientific services, has been granted FDA approval for its Ion Torrent™ Oncomine™ Dx Target Test as a companion diagnostic to select patients suitable for treatment with Servier Pharmaceuticals, LLC’s...
Ionis Pharmaceuticals, Inc. revealed that the Committee for Medicinal Products for Human Use (CHMP) in the European Union (EU) has recommended the approval of Ionis' and AstraZeneca's Wainzua (eplontersen) for treating hereditary transthyretin...
Oculis Holding AG (Oculis) has sped up the enrollment of patients for the phase 3 DIAMOND clinical trials of OCS-01 eye drops in DME and expanded the DIAMOND programme committees with leading retina specialists worldwide. Significant advancement...
The anti-diabetes market has tripled to almost Rs 17,000 crore, and the cardiac market has more than doubled to nearly Rs 30,000 crore from its 2014 levels of Rs 5,000 crore and Rs 10,000 crore, respectively. Sheetal Sapale, vice president of...
Akums Drugs & Pharmaceuticals, a CDMO, has entered into a strategic partnership with Triple Hair Group, a Canadian company focusing on creating new remedies for androgenic alopecia. This is specifically for the exclusive licensing of their...
Boston Scientific Corporation, a leading global medical technology company, stated it got approval from the US FDA for the Farawave NAV Ablation Catheter and FDA 510(k) clearance for the Faraview Software, both used in treating paroxysmal atrial...
Alembic Pharmaceuticals Ltd announced that it has obtained approval from the US health regulator for its generic Diltiazem Hydrochloride extended-release capsules, which are used for treating hypertension. The company stated that the USFDA has...
, CDSCO.jpg)
